Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Endosc. Aug 16, 2021; 13(8): 319-328
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.319
Table 4 Univariate and multivariate analysis for disease-free survival and overall survival
Disease-free survival
Univariate analysis

Multivariate analysis

Variables
HR
95%CI
P value
HR
95%CI
P value
Male (vs female)0.990.47–2.080.975
Age (< 62 yr vs > 62 yr)0.870.56–3.140.873
Siewert 1 vs 21.110.14–8.890.921
TH vs TT (1, 2A)1.711.01–2.900.0461.731.00–2.990.049
Post-operative complications1.220.56-2.060.961
G3 (vs G1/G2)1.140.61–2.130.690
LN+/LN-2.611.71-3.560.0011.770.99-3.240.101
pT3/pT4 status (vs pT0/T1/pT2)2.211.86–7.310.0031.560.97-3.890.102
pN+ (vs pN0)2.541.57-5.780.051.430.88-3.320.103
Pathological exam
Lymphatic0.780.39-1.290.783
Venous1.670.35-2.720.246
Neural0.780.67-1.890.183
Overall survivalUnivariate analysisMultivariate analysis
VariablesHR95%CIP valueHR95%CIP value
Age (< 62 yr vs > 62 yr)0.980.89-5.130.821
Siewert 1 vs 21.310.16-10.680.799
TH vs TT (1, 2A)2.011.19-3.390.0091.791.03-3.090.038
Post-operative complications1.030.60-1.740.927
G3 (vs G1/G2)2.371.36-4.160.0032.541.33-4.820.005
LN+/LN-1.721.00-3.480.0501.210.87-3.460.732
pT3/pT4 status (vs pT0/T1/pT2)5.951.81-19.610.0039.962.43-40.740.001
pN+ (vs pN0)1.681.38-3.900.0021.180.86-4.990.735
Pathological exam
Lymphatic0.470.23-1.780.109
Venous0.490.20-1.060.076
Neural1.800.96-3.350.065